Phase II Window Study of Two Dose Levels of SAR439859 SERD Versus Letrozole in Newly Diagnosed Pre-Operative Post-Menopausal Patients with ER Positive, HER2 Negative Primary Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04191382

Study #:
STUDY00145320

Start Date:
Aug 25, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04191382

View Complete Trial Details & Eligibility at ClinicalTrials.gov